These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8923856)

  • 1. Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia.
    Shohat M; Tick D; Barakat S; Bu X; Melmed S; Rimoin DL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4033-7. PubMed ID: 8923856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-promoting effect of human growth hormone on patients with achondroplasia.
    Okabe T; Nishikawa K; Miyamori C; Sato T
    Acta Paediatr Jpn; 1991 Jun; 33(3):357-62. PubMed ID: 1785332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
    Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of achondroplasia with growth hormone: six years of experience.
    Ramaswami U; Rumsby G; Spoudeas HA; Hindmarsh PC; Brook CG
    Pediatr Res; 1999 Oct; 46(4):435-9. PubMed ID: 10509364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal dysplasia, growth hormone treatment and body proportion: comparison with other syndromic and non-syndromic short children.
    Hagenäs L; Hertel T
    Horm Res; 2003; 60 Suppl 3():65-70. PubMed ID: 14671400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
    Lampit M; Hochberg Z
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of growth hormone therapy in children with achondroplasia: growth pattern, hypothalamic-pituitary function, and genotype.
    Tanaka H; Kubo T; Yamate T; Ono T; Kanzaki S; Seino Y
    Eur J Endocrinol; 1998 Mar; 138(3):275-80. PubMed ID: 9539301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human growth hormone treatment in prepubertal children with achondroplasia.
    Weber G; Prinster C; Meneghel M; Russo F; Mora S; Puzzovio M; Del Maschio M; Chiumello G
    Am J Med Genet; 1996 Feb; 61(4):396-400. PubMed ID: 8834055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia.
    Tanaka N; Katsumata N; Horikawa R; Tanaka T
    Endocr J; 2003 Feb; 50(1):69-75. PubMed ID: 12733711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable Growth Hormone Treatment Response in a Young Boy with Achondroplasia.
    Krstevska-Konstantinova M; Stamatova A; Gucev Z
    Med Arch; 2016 Apr; 70(2):148-50. PubMed ID: 27147792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present status of the use of growth hormone in short children with bone diseases (diseases of the skeleton).
    Kanaka-Gantenbein C
    J Pediatr Endocrinol Metab; 2001 Jan; 14(1):17-26. PubMed ID: 11220700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal.
    Leger J; Garel C; Fjellestad-Paulsen A; Hassan M; Czernichow P
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3512-6. PubMed ID: 9768656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress report: growth hormone in skeletal dysplasia.
    Bridges NA; Brook CG
    Horm Res; 1994; 42(4-5):231-4. PubMed ID: 7868078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth characteristics and response to growth hormone therapy in patients with hypochondroplasia: genetic linkage of the insulin-like growth factor I gene at chromosome 12q23 to the disease in a subgroup of these patients.
    Mullis PE; Patel MS; Brickell PM; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1991 Apr; 34(4):265-74. PubMed ID: 1879059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone therapy in achondroplasia.
    Horton WA; Hecht JT; Hood OJ; Marshall RN; Moore WV; Hollowell JG
    Am J Med Genet; 1992 Mar; 42(5):667-70. PubMed ID: 1632435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of recombinant human growth hormone in Noonan syndrome.
    Ogawa M; Moriya N; Ikeda H; Tanae A; Tanaka T; Ohyama K; Mori O; Yazawa T; Fujita K; Seino Y; Kubo T; Tanaka H; Nishi Y; Yoshimoto M
    Endocr J; 2004 Feb; 51(1):61-8. PubMed ID: 15004410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Growth Hormone Treatment in Skeletal Dysplasia - A Review.
    Kochar IS; Chugh R
    Pediatr Endocrinol Rev; 2020 Aug; 17(4):327-330. PubMed ID: 32780956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA; Hassing JM
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone therapy in hypochondroplasia.
    Ramaswami U; Hindmarsh PC; Brook CG
    Acta Paediatr Suppl; 1999 Feb; 88(428):116-7. PubMed ID: 10102069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.